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1.1 Reagents and chemicals 
Reagents and chemicals were purchased from Sigma Aldrich and used without further 
purification.  
1.2 Non-canonical amino acid analogues 
 N-Boc-4-cyano-L-phenylalanine was purchased from ABCR Germany (AB156069). Boc protecting 
group was removed by treatment with HCl 4M in dioxane at room temperature (Scheme 1, 
supporting information). The purity of the p-cyano-L-phenylalanine (pCNF) hydrochloride 
product was monitored by 1H NMR, 13C NMR and MS-ESI. All characterizations match 












Scheme S1: deprotection of N-Boc-p-cyano-(L)-phenylalanine 
Procedure: In an Ar-purged flask containing 1.5 g (5.2 mmol) of N-Boc-p-cyano-(L)-phenylalanine, 
10 mL of HCl 4 M were added in an ice bath, while stirring. After 2 h at 0°C, the ice bath was 
removed and the reaction mixture was kept at room temperature for another hour. The solvent 
was removed by vacuum evaporation and lyophilization. The product p-cyano-(L)-
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phenylalanine hydrochloride was obtained in 92 % yield (1.1 g, 4.8 mmol) . 1H NMR (400 MHz, 
D2O, ppm) δ 7.76 (m, 2H) 7.47 (m, 2H) 4.31 (dd, J=7.5, J=5.9, 
1H) 3.84 (m, 2H); 13C NMR (100 MHz, 
D2O, ppm) δ 171.4, 140.58, 133.37, 130.52, 119.72, 110.86, 54.30, 36.11; MS-ESI [m/z]
+= 
191.0817; calcd for [C10H11N2O2]
+=191.0821.  
1.3 Plasmids 
The genes encoding horse heart CytC with N-terminal hexahistidine tag and TEV restriction site 
together with yeast cytochrome c heme lyase (CCHL) are arranged in a pET22b expression vector 
(Novagen) under the control of a T7 promotor. Eight single codons (corresponding tot he amino 
acids AA=Phe10, Phe36, Tyr48, Trp59, Tyr67, Tyr74, Phe82, Tyr97) of the CytC gene sequence 
were mutated to an amber (TAG) stop codon by site-directed mutagenesis to generate 
pET22b+CytC(Codon→TAG)+CCHL. The plasmid sequences have been verified by DNA 
sequencing analysis. 
The plasmid pEVOL-pCNF-RS[3,4] bearing the orthogonal non-sense suppressor tRNA/aminoacyl-
tRNA synthetase pair and a chloramphenicol resistance was kindly provided by Dr. Peter Schultz 
laboratory. 























































































2.  Biosynthesis of cytochrome c and sequences 
Heterologous expression of horse heart CytC is a complex system as several enzymes are 
involved in the biosynthesis of the heme cofactor.[5] In the performed experiments we co-
expressed the yeast cytochrome c heme lyase (CCHL) for enhanced catalysis of the attachment 
of the heme cofactor to CytC.[6] Both synthesis of heme and attachment to CytC are crucial steps 
for generating soluble and catalytically active CytC.  
 
Scheme S2: Biosynthesis of heme[5] and recombinant expression of horse heart CytC in E.coli. 
The cofactor can be attached to CytC by the intrinsic maturation system of E.coli or by a 



















In the gene encoding pCNF36-CytC mutant, codon TTT of CytC DNA sequence was mutated to 







His-Tag TEV-restriction site 
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3. Bacterial strains and culture conditions 
3.1 Strains 
E. coli strain BL-21(DE3) was transformed with pET22b+CytC+CCHL or co-transformed with 
pEVOL-pCNF-RS and pET22b+CytC(Codon→TAG)+CCHL respectively. Chloramphenicol (25 µg/mL) 
and ampicillin (50 µg/mL) were used for selection. 
3.2 Incorporation of the non-canonical amino acid analog 
E. coli strain BL-21(DE3) was co-transformed with the pEVOL-pCNF-RS and 
pET22b+CytC(Codon→TAG). After overnight incubation on plates, single colonies were 
transferred into 5 ml LB medium and grown at 37°C overnight. This culture (2 mL) was used to 
inoculate 2 L of ZYP5052[8] self-inducing media containing chloramphenicol (37 μg/mL) and 
ampicillin (100 μg/mL) in a 5 L erlenmeyer flask. 0.2 % Arabinose to induce pCN-RS expression, 
0.028 g/L ferric ammonium citrate and 0.1 mM δ-aminolevulinic as heme precursors, 0.1 mM 
pCNF to supplement basal expression of CytC and 2 mM MgSO4 were added. The culture was 
grown at 23°C while shaking for 24 h to express CCHL. Afterwards pCNF concentration was 
increased to 2 mM and the culture was grown at 30°C for another 48 h under constant shaking 
(200 rpm) for ensuring high pCNF-RS activity and CytC expression rate. Cells were harvested by 
centrifugation for 20 min at 8000 rpm using an Eppendorf Centrifuge 5810R. A similar procedure 
was used to express wt-CytC using a pET22b+CytC plasmid with no mutation on horse heart CytC 
sequence.  The two-step temperature ramp expression protocol was developed in order to 
secure expression of active CytC maturing machinery (CCHL for heme attachment to CytC and 
enzymes involved in heme synthesis). Furthermore ZYP-5052 media contains a phosphate buffer, 
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which enables on one hand for the growth to a high optical density as well as long incubation 
times, which secures proper maturing of CytC. 
 
Scheme S3: Schematic representation of the temperature ramp up expression of CCHL 
heme lyase and CytC 
4. Stop codon read-through determination by SDS-PAGE 
and Western Blot 
 
Scheme S4: View of CytC (PDB ID: 1HRC) and targeted residues (black) for substitution 
with p-cyano-phenylalanine. The cofactor heme is highlighted in blue. 
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It is reported, that incorporation rate via SCS of the non-canonical amino is influenced by the 
nucleotides surrounding the nonsense codon (here amber stop codon) .[9] Detection of CytC via 
Western Blot was performed using a monoclonal  CytC antibody (7H8.2C12) from Thermo 
Scientific. 
 
Figure S1: Detection of stop-codon read-through at various positions in CytC by SDS-
PAGE Gels (20 %) and Western Blots using a monoclonal CytC antibody (7H8.2C12) from 
Thermo Scientific. Loaded are the total fractions (tot.) after 24 h expression at 23°C and 
the soluble (sol.) and insoluble (ins.) fraction after lysis of cells incubated another 48 h at 
30°C. m: PageRuler Prestained Protein Ladder. Wt-CytC (Mcalc=14396.1 Da), FpCNF-
CytC (Mcalc=14421.1 Da), YpCNF-CytC (Mcalc=14405.1 Da), WpCNF-CytC 
(Mcalc=14382.1 Da).  Appearance of corresponding bands is in the region of the 15 kDa 
band of the PageRuler Prestained Ladder and indicated with an arrow. 
 
Substitution at position tryptophan 59 (W59) and tyrosine 74 (Y74) resulted in insoluble CytC´s. 
CytC variants with pCNF at the positions phenylalanine 36 (F36), F82, F10, tyrosine 67 (Y67) and 
Y97 showed at least partial expression in the soluble fraction. Eight out of nine positions allowed 
efficient read-through, with the exception of position 48 resulting in no detectable product. 
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5. Purification of proteins 
5.1 Lysis 
The pellets of 1 L liquid culture were re-suspended in 80 mL lysis buffer (pH 8.0) containing 50 
mM TRIS, 150 mM NaCl, 20 mM imidazole, 40 µg/mL DNase I and RNase A and 1 mM 
phenylmethylsulfonyl fluoride. Lysis was carried out in 5 cycles of 2 min sonication (Sonoplus 
HD3200, KE76 electrode) using a 60 % amplitude at an interval of 1 s pulse and 4 s pause.   
5.2 Purification from soluble fraction 
Cell debris were collected by centrifugation (12 000 x g, 40 min). The supernatant was purified 
by a pre-equilibrated Ni-NTA affinity column on the ÄKTApure FPLC system from GE Healthcare 
using a linear gradient of elution buffer (TRIS 50 mM, NaCl 150 mM, 500 mM imidazole, pH 8.0). 
Fractions absorbing at 550 nm were collected, dialyzed against phosphate buffer (Na3PO4 
100 mM, pH 7.4) and subsequently concentrated. The dialyzed sample was loaded onto a pre-
equilibrated S-Sepharose cation-exchange column and recombinant CytC was eluted with a 
high-salt buffer (Na3PO4 100 mM, NaCl 500 mM, pH 7.4) using a linear gradient. Fractions with 
absorption at 550 nm were collected, dialyzed against phosphate buffer (Na3PO4 100 mM, 
pH 7.4) concentrated and stored at 4°C.  
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Figure S2: SDS-PAGE gels showing the purification steps of wt-CytC and and F36pCNF-
CytC. Loaded are the total fractions (tot.) after 24 h expression at 23°C and the soluble 
(sol.) and insoluble (ins.) fraction after lysis of cells incubated another 48 h at 30°C as 
well as the purified proteins after immobilized metal (Ni2+) affinity chromatography 
(IMAC) and (cat)ion-exchange chromatography (IEX). m: PageRuler Prestained Protein 
Ladder. 
 
5.3 Purification from insoluble fraction and refolding 
Insoluble fractions were resuspended in denaturing solubilization buffer (50mM TRIS, 150 mM 
NaCl, 6M GndCl, pH 8.0) to solubilize inclusion bodies. Samples were sonicated (KE5 electrode, 
52 % amplitude, 1 sec pulse, 2 sec pause, 2 min) and centrifuged at 12 000 x g for 40 min to 
remove insoluble material. The supernatant was purified by affinity chromatography (Ni-Column) 
in presence of GndCl 6M in both binding and elution buffers. After purification, the samples 
were dialyzed overnight against buffer (50 mM TRIS, 150 mM NaCl, pH 8.0). After dialysis a 
precipitate was formed. Precipitate was isolated by centrifugation (12 000 x g,  30 min) and both 
fractions soluble and pellet were analyzed by SDS-PAGE gel and Western Blot.  
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Figure S3: SDS-PAGE gels showing the purification steps CytC(Y74pCNF). Loaded are 
the total fractions after 24 h expression at 23°C and the soluble and insoluble fraction 
after lysis of cells incubated another 48 h at 30°C as well as the purified proteins after 
immobilized metal (Ni2+) affinity chromatography (IMAC) and (cat)ion-exchange 
chromatography (IEX). m: PageRuler Prestained Protein Ladder. 
6. Analytical characterization 
6.1 Protein concentration 
The final concentrations of recombinant pCNF-CytC mutants and wild-type CytC were 
determined by using an extinction coefficient of 29.0 mM at 505 nm. [10] 
6.2 HPLC-ESI-MS 
The mass of the purified proteins was analyzed by LC-ESI-MS. 10 µL of the purified protein with 
a concentration of 0.1-0.3 mg/mL were injected. First, proteins were pre-seperated on a C5 
column (Supelco Analytical, Sigma-Aldrich) by reversed-phase chromatography with a gradient 
of 20 % - 90 % acetonitrile and afterwards transmitted to the mass spectrometer Exactive 
(Thermo Scientific, Waltham, MA, USA). Ionization was conducted via electrospray ionization 
(ESI) and mass analysis via orbitrap. The obtained spectrum was deconvoluted with the program 
MagTran to obtain the molecular mass. 
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Figure S4: deconvoluted ESI-MS profiles of purified wt-CytC (Mcalc=14396.1 Da) and 
pCNF-CytC (Mcalc=14421.1 Da). 
6.3 UV-absorption, CD-spectra and thermal unfolding of 
CytC variants 
Electronic spectra (UV-visible) were recorded on a JASCO J-815 spectrometer at room 
temperature in the wavelength range 300-800 nm using a standard 10 mm path length quartz 
cuvette. Circular Dichroism (CD) spectra were collected in a JASCO J-815 spectrometer 
employing a 1 mm quartz cuvette. Secondary structure of oxidized CytC samples was analyzed 
by recording far-UV CD spectra (199–255 nm) at 25°C. Protein concentration was 25 μM in 
100 mM sodium phosphate buffer (pH 7.4), supplemented with 50 μM potassium ferricyanide. 
Thermal unfolding was monitored between 20°C and 98°C by recording the CD signal at 220 nm. 
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Figure S5: Absorption spectra for heterologously expressed CytC variants with pCNF 
incorporated at the indicated positions at 25°C in 100 mM phosphate buffer pH 7.4. 
 
Figure S6.  Effect of the pCNF substitution on the thermal stability of oxidized CytC 
mutants (○)wt-CytC; (□)pCNF-CytC. The Tm values of the pCNF-CytC and wt-CytC species 
were calculated from theoretical fitting (indicated as solid lines) of the 220 nm CD signal 






6.4 Infrared absorption spectroscopy 
IR spectra were measured with a spectral resolution of 4 cm-1 using a Bruker Tensor 27 FT-IR 
spectrometer controlled by the OPUS Data Collection Program. Each spectrum consisted of 400 
scans. All measurements were carried out at room temperature (25C). 
6.5 Electrochemistry 
Cyclic voltammetric measurements of immobilized CytC variants were performed with a 
multistat CH instrument controlled by the CH Labs-CHI 660b software. The scan rate was varied 
in the range from 0.1 - 1 Vs-1. The proteins were immobilized on Ag electrodes coated with self-
assembled monolayers of mercaptohexanoic acid as described previously. [11] The solution 
contained 12.5 mM potassium sulfate and 12.5 mM sodium phosphate buffer at pH = 7.0. 
Solutions were purged with Ar prior to the experiments. 
 
 
Figure S7. Variations of the anodic (○) and cathodic (●) peak currents of pCNF-CytC 





7. Summary of expressed CytC congeners 
Substituted 
residue 







Wild-type - - Mostly 
soluble 
Supernatant No  
F10 Partly 
buried 
Protein interior Partly 
soluble 
Supernatant No  
F36 Surface Protein interior Soluble Supernatant No 2 methionines 
oxidized 
Y48  Partly 
buried 
Protein interior - - -  
W59 Partly 
buried 
- Insoluble Inclusion 
bodies 
Yes  
Y67 Buried Protein interior Partly 
soluble 
Supernatant Yes  
Y74 Surface Solvent Insoluble Inclusion 
bodies 
Yes  
F82 Surface Protein interior Partly 
soluble 
Supernatant Yes  
 
Table S1. Summary of expression and properties of CytC variants with pCNF 
incorporated at different positions. 
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